These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10657531)

  • 1. A radioiodinated 7alpha-O-iodoallyl diprenorphine for mapping opioid receptors.
    Wang RF; Tafani JA; Zajac JM; Guiraud R
    Neuropeptides; 1999 Dec; 33(6):498-502. PubMed ID: 10657531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoradiographic and SPECT imaging of cerebral opioid receptors with an iodine-123 labeled analogue of diprenorphine.
    Lever JR; Ilgìn N; Musachio JL; Scheffel U; Finley PA; Flesher JE; Natarajan TK; Wagner HN; Frost JJ
    Synapse; 1998 Jun; 29(2):172-82. PubMed ID: 9593107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of [125I]7 alpha-O-iodoallyl diprenophine as a new potential SPECT opioid receptor imaging agent.
    Wang RF; Tafani JA; Francés B; Bergon M; Coulais Y; Zajac JM; Guiraud R
    Nucl Med Biol; 1997 Aug; 24(6):553-8. PubMed ID: 9316084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of opioid-binding sites in zebrafish brain.
    González-Núñez V; Barrallo A; Traynor JR; Rodríguez RE
    J Pharmacol Exp Ther; 2006 Feb; 316(2):900-4. PubMed ID: 16207834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6-O-(2-[18F]fluoroethyl)-6-O-desmethyldiprenorphine ([18F]DPN): synthesis, biologic evaluation, and comparison with [11C]DPN in humans.
    Wester HJ; Willoch F; Tölle TR; Munz F; Herz M; Oye I; Schadrack J; Schwaiger M; Bartenstein P
    J Nucl Med; 2000 Jul; 41(7):1279-86. PubMed ID: 10914922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent cannabinergic indole analogues as radioiodinatable brain imaging agents for the CB1 cannabinoid receptor.
    Deng H; Gifford AN; Zvonok AM; Cui G; Li X; Fan P; Deschamps JR; Flippen-Anderson JL; Gatley SJ; Makriyannis A
    J Med Chem; 2005 Oct; 48(20):6386-92. PubMed ID: 16190764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
    Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of aquaporin4 deficiency on opioid receptors characteristics in naive and chronic morphine-treated mice.
    Wang JF; Wang ZY; Wu N; Yan HT; Li J
    Neurosci Lett; 2009 Jul; 457(3):111-4. PubMed ID: 19429174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, radiolabeling, in vitro and in vivo evaluation of [18F]-FPECMO as a positron emission tomography radioligand for imaging the metabotropic glutamate receptor subtype 5.
    Lucatelli C; Honer M; Salazar JF; Ross TL; Schubiger PA; Ametamey SM
    Nucl Med Biol; 2009 Aug; 36(6):613-22. PubMed ID: 19647167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of l-DOPA-induced dyskinesia.
    Johansson PA; Andersson M; Andersson KE; Cenci MA
    Neurobiol Dis; 2001 Apr; 8(2):220-39. PubMed ID: 11300719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of specific opioid binding sites in neural membranes from the myenteric plexus of porcine small intestine.
    Townsend D; Portoghese PS; Brown DR
    J Pharmacol Exp Ther; 2004 Jan; 308(1):385-93. PubMed ID: 14569065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography.
    Goodman MM; Chen P; Plisson C; Martarello L; Galt J; Votaw JR; Kilts CD; Malveaux G; Camp VM; Shi B; Ely TD; Howell L; McConathy J; Nemeroff CB
    J Med Chem; 2003 Mar; 46(6):925-35. PubMed ID: 12620070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of changes in opioid receptor binding in vivo during trigeminal neuralgic pain using [11C] diprenorphine and positron emission tomography.
    Jones AK; Kitchen ND; Watabe H; Cunningham VJ; Jones T; Luthra SK; Thomas DG
    J Cereb Blood Flow Metab; 1999 Jul; 19(7):803-8. PubMed ID: 10413036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-O-(2-[
    Levinstein MR; Ventriglia EN; Gomez JL; Budinich RC; Marton J; Henriksen G; Holt DP; Dannals RF; Pomper MG; Zarate CA; Bonaventura J; Michaelides M
    Mol Imaging Biol; 2023 Apr; 25(2):384-390. PubMed ID: 35999424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoradiography in opioid triple knockout mice reveals opioid and opioid receptor like binding of naloxone benzoylhydrazone.
    Cox V; Clarke S; Czyzyk T; Ansonoff M; Nitsche J; Hsu MS; Borsodi A; Tömböly C; Tóth G; Hill R; Pintar J; Kitchen I
    Neuropharmacology; 2005 Feb; 48(2):228-35. PubMed ID: 15695161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative in vitro phosphor imaging using [3H] and [18F] radioligands: the effects of chronic desipramine treatment on serotonin 5-HT2 receptors.
    Strome EM; Jivan S; Doudet DJ
    J Neurosci Methods; 2005 Jan; 141(1):143-54. PubMed ID: 15585298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piperazine analog of vesamicol: in vitro and in vivo characterization for vesicular acetylcholine transporter.
    Bando K; Naganuma T; Taguchi K; Ginoza Y; Tanaka Y; Koike K; Takatoku K
    Synapse; 2000 Oct; 38(1):27-37. PubMed ID: 10941138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and pharmacological characterization of a novel, highly potent, peptidomimetic delta-opioid radioantagonist, [3H]Tyr-Tic-(2S,3R)-beta-MePhe-Phe-OH.
    Birkas E; Kertesz I; Toth G; Bakota L; Gulya K; Szucs M
    Neuropeptides; 2008 Feb; 42(1):57-67. PubMed ID: 18068762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-(3-[18F]fluoropropyl)-N-nordiprenorphine: synthesis and characterization of a new agent for imaging opioid receptors with positron emission tomography.
    Chesis PL; Hwang DR; Welch MJ
    J Med Chem; 1990 May; 33(5):1482-90. PubMed ID: 2158564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM; Qian X; Schiller PW; Szeto HH
    J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.